1995-2000
On February 19, 1995, the construction of Rizhao Oceanic Pharmaceutical Plant of Shandong Jiejing Group was successfully started, which was a firm step taken by Jiejing Group following the formation of the scale of the chemical plant, and the project was listed as a key technological transformation project of Rizhao in the year of 1995 at the same time.
On May 1, 1996, the trial production of Ocean Pharmaceutical Plant was successful.
In 1998, the company was the first one to pass the GMP standard in the infusion industry in Shandong Province.
2001-2005
On November 3, 2001, Shandong Jiejing Group and Shanghai Changzheng Fumin Pharmaceutical Co., Ltd*** invested the same capital, and Shandong Changfu Jiejing Pharmaceutical Co., Ltd. was formally established with the theme of the former Jiejing Group's Rizhao Oceanic Pharmaceutical Factory.
In 2002, the company was recognized by the Science and Technology Department of Shandong Province as "High-tech Enterprise of Shandong Province".
In 2003, the company was awarded "Provincial Contract and Trustworthy Enterprise" by Shandong Province Administration for Industry and Commerce and Shandong Province Enterprise Management Association.
In 2004, the company was awarded AAA grade of Rizhao enterprise credit rating.
In June 2004, the company's plastic bottle infusion production line successfully passed the national GMP certification inspection.
In May, 2005, the three glass bottle infusion production lines of the company's Infusion I Workshop and Infusion II Workshop successfully passed the GMP certification inspection.
On September 9, 2005, the foundation stone laying ceremony of the pharmaceutical industrial park project was held.
November 2005, the company's product Jiejing brand I.V. Infusion solution was awarded as "Shandong Famous Brand Product".
In 2005, the company was awarded the title of "Double Love and Double Evaluation" advanced enterprise at the provincial level
2006-2010
July 2006, the company's first API, Hydroxyethyl Starch 130/0.4, was granted with production approval.
In November 2006, the two production lines of API (Hydroxyethyl Starch 130/0.4) and flushing agent of the company successfully passed GMP certification.
In February 2007, the first production line of polypropylene infusion bottles with an annual capacity of 30 million bottles in the new park passed the national pharmaceutical GMP certification.
In May, 2007, Zemu (Hydroxyethyl Starch 130/0.4 Sodium Chloride Injection), which was manufactured by the company itself, was successfully launched.
November 2007, the first production line of glass infusion bottles with an annual capacity of 60 million bottles and the second production line of polypropylene infusion bottles with an annual capacity of 50 million bottles in the park passed the national drug GMP certification.
In December 2007, the API (hydroxyethyl starch 130/0.4) production line with an annual output of 100 tons passed the GMP certification of the provincial bureau.
In February 2008, the company's technology center was officially recognized as "Shandong Province Enterprise Technology Center".
In February 2008, the company completed the relocation from the old factory to the new factory.
August 2008, the company's first multi-layer **** extrusion infusion bag production line passed the GMP certification of the State Bureau.
In December 2008, the second multi-layer **** extrusion bag production line for infusion, the second glass infusion bottle production line, and rinse agent (polypropylene infusion bottle) passed the GMP certification of the National Bureau.
In November 2009, the company's annual output of 30 tons of API (glucose condensed) production line passed the provincial bureau GMP certification.
On January 11, 2010, the company became a wholly-owned subsidiary of Shandong Jiejing Group through the change of business registration.
In April 2010, the company was officially renamed as Shandong Jiejing Pharmaceutical Co.
From April 16 to 18, 2010, the company's ribavirin dextrose injection successfully passed the on-site verification of the State Food and Drug Administration.
On June 9, 2010, the company's Levofloxacin Sodium Chloride Injection successfully passed the follow-up inspection of the State Food and Drug Administration.
On November 23, 2010, the company successfully passed the on-site inspection for the renewal of Drug Manufacturing License.
On November 27, 2010, the two specifications of the company's Hydroxyethyl Starch 130/0.4 Sodium Chloride Injection (Soft Bag) successfully passed the on-site verification of Shandong Food and Drug Administration.
On December 29, 2010, the company was awarded "AAA Grade Harmonious Labor Relations Enterprise" by Rizhao Leading Group of Creating Harmonious Labor Relations Enterprise.
2011
January 2011, the API workshop of the company was jointly named as the 2010 "Youth Work Safety Demonstration Post of Shandong Province" by the Shandong Provincial Committee of the Youth League and Shandong Provincial Safety Production Supervision Administration.
On February 11, 2011, the company was awarded the honorary title of "Top Ten Enterprises in Donggang District" again.
March 1, 2011, the company's drug electronic monitoring and coding project trial production success.